Quick Takeaways
- Sheldon Sloan has 1 issuer position tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Sheldon Sloan
- Location
- Waltham, MA
- Signature
- /s/ Heidy King-Jones, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Sheldon Sloan and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Spyre Therapeutics, Inc. ($0).
- Past-year value change for that position: -$397,900.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Sheldon Sloan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | Chief Medical Officer | $0 | -$397,900 | -100% | 01 Apr 2026 |
Insider Transactions Reported by Sheldon Sloan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.